
USD $402.00
Prolia or Xgeva, containing the active ingredient Denosumab, is an innovative medication designed for the treatment of various conditions related to bone health. Denosumab is a monoclonal antibody that works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This mechanism helps to strengthen bones and reduce the risk of fractures.
Prolia or Xgeva (Denosumab) 60mg/ml x 1 Single prefilled syringe is a other supplied in 60mg. Use only under medical supervision.